Frequency and effectiveness of dose increase of adalimumab, etanercept, and infliximab in daily clinical practice.

Abstract

OBJECTIVE To describe the frequency and effectiveness of dose increase of adalimumab, etanercept, and infliximab in the treatment of rheumatoid arthritis (RA) in daily clinical practice. METHODS All RA patients with a dose increase of tumor necrosis factor (TNF)-blocking therapy between January 1997 and January 2008 were selected from a register including… (More)
DOI: 10.1002/acr.20211

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.